Management of Recurrent Thrombosis in Antiphospholipid Syndrome

被引:29
|
作者
Nalli, Cecilia [1 ,2 ,3 ]
Andreoli, Laura [1 ,2 ]
Casu, Cinzia [4 ]
Tincani, Angela [1 ,2 ]
机构
[1] Spedali Civil Brescia, Dept Clin & Expt Sci, I-25125 Brescia, Italy
[2] Univ Brescia, Brescia, Italy
[3] Univ Pavia, Rheumatol Chair, I-27100 Pavia, Italy
[4] Osped Niguarda Ca Granda, Rheumatol Unit, Milan, Italy
关键词
Antiphospholipid antibodies; Anticardiolipin antibodies; Anti-ss 2glycoprotein I antibodies; Lupus anticoagulant; Thrombosis; Recurrent thrombosis; Stroke; Primary antiphospholipid syndrome; Cardiovascular risk; SYSTEMIC-LUPUS-ERYTHEMATOSUS; DEEP VENOUS THROMBOSIS; RISK-FACTORS; ANTICARDIOLIPIN ANTIBODIES; ANTICOAGULATION TREATMENT; CLINICAL-COURSE; TASK-FORCE; PREVENTION; APS; MULTICENTER;
D O I
10.1007/s11926-013-0405-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
One of the challenges of managing patients with antiphospholipid syndrome is the prevention of rethrombosis (secondary prophylaxis). Risk stratification, i.e. traditional cardiovascular and thrombosis risk factors, systemic autoimmune diseases, antiphospholipid antibody profile, and the intensity of anticoagulation are all relevant to the management of APS patients with recurrent thrombosis. The paper will review "state of the art" strategies for optimizing therapy for APS patients with recurrent thrombosis.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Diagnosis and management of catastrophic antiphospholipid syndrome
    Carmi, Or
    Berla, Maya
    Shoenfeld, Yehuda
    Levy, Yair
    EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (04) : 365 - 374
  • [32] Cerebral sinovenous thrombosis in neonatal antiphospholipid syndrome: a new entity?
    De Carolis, M. P.
    Salvi, S.
    Botta, A.
    Cocca, C.
    Garufi, C.
    Lanzone, A.
    De Carolis, S.
    LUPUS, 2015, 24 (03) : 231 - 234
  • [33] Antiphospholipid syndrome
    Lim, Wendy
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2013, : 675 - 680
  • [34] Management of antiphospholipid syndrome
    Saadoun, D.
    Piette, J-C.
    Wahl, D.
    Costedoat-Chalumeau, N.
    REVUE DE MEDECINE INTERNE, 2012, 33 (04): : 217 - 222
  • [35] The impact of antibody profile in thrombosis associated with primary antiphospholipid syndrome
    Saraiva, Sabrina da Silva
    Mazetto, Bruna de Moraes
    Tobaldine, Lais Quinteiro
    Colella, Marina Pereira
    de Paula, Erich Vinicius
    Annichinno-Bizzachi, Joyce
    Orsi, Fernanda Andrade
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (11) : 1163 - 1169
  • [36] Antiphospholipid syndrome
    Khamashta, M.
    Taraborelli, M.
    Sciascia, S.
    Tincani, A.
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2016, 30 (01): : 133 - 148
  • [37] Antiphospholipid Antibodies and Antiphospholipid Syndrome: Role in Portal Vein Thrombosis in Patients With and Without Liver Cirrhosis
    Amitrano, Lucio
    Ames, Paul R. J.
    Guardascione, Maria Anna
    Lopez, Luis R.
    Menchise, Antonella
    Brancaccio, Vincenzo
    Iannaccone, Luigi
    Balzano, Antonio
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2011, 17 (04) : 367 - 370
  • [38] Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio
    Amory, Colum F.
    Levine, Steven R.
    Brey, Robin L.
    Gebregziabher, Mulugeta
    Tuhrim, Stanley
    Tilley, Barbara C.
    Simpson, Ann-Catherin C.
    Sacco, Ralph L.
    Mohr, Jay P.
    CEREBROVASCULAR DISEASES, 2015, 40 (5-6) : 293 - 300
  • [39] Hydroxychloroquine A new approach of thrombosis in the antiphospholipid syndrome
    Szymezak, J.
    Ankri, A.
    Fischer, A-M
    Darnige, L.
    REVUE DE MEDECINE INTERNE, 2010, 31 (12): : 854 - 857
  • [40] Anticoagulation in Management of Antiphospholipid Antibody Syndrome in Pregnancy
    Lockshin, Michael D.
    CLINICS IN LABORATORY MEDICINE, 2013, 33 (02) : 367 - +